Abstract

Anaphylaxis is a source of anxiety for patients and healthcare providers. It is a medical emergency that presents with a broad array of symptoms and signs, many of which can be deceptively similar to other diseases such as myocardial infarction, asthma, or panic attacks. In addition to these diagnostic challenges, anaphylaxis presents management difficulties due to rapid onset and progression, lack of appropriate self-treatment education and implementation by patients, severity of the allergic response, exacerbating medications or concurrent disease, and unpredictability. The most common causes of anaphylaxis are food allergies, stinging insects and immunotherapy (allergy shots) but idiopathic anaphylaxis, latex allergy and drug hypersensitive all contribute to the epidemiology. Reactions to IVP and other dyes are coined anaphylactoid reactions but have identical pathophysiology and treatment, once the mast cell has been degranulated. As many antigens can be the trigger for fatal anaphylaxis, it is useful to examine the features of each etiology individually, highlighting factors common to all fatal anaphylaxis and some specific to certain etiologies. Generally what distinguishes a fatal from non fatal reaction is often just the rapidity to apply correct therapy. Prevention is clearly the key and should identify high-risk patients in an attempt to minimize the likely of a severe reaction. Although fatal anaphylaxis is rare, it is likely underreported.

Highlights

  • The term “anaphylaxis” entered the scientific literature in 1902, when Richet and Potier described the hypotensive effects of sea anemone allergens in dogs (Cohen and Zelaya-Quesada 2002)

  • Anaphylaxis implies an immunoglobulin E (IgE)-mediated release of mediators from mast cells and basophils after antigen causes cross-linking of the IgE receptors on these cells

  • The lessons gleaned from reviews of cases of fatal anaphylaxis may help physicians understand why people die and may help initiate management approaches that prevent anaphylaxis

Read more

Summary

Introduction

The term “anaphylaxis” entered the scientific literature in 1902, when Richet and Potier described the hypotensive effects of sea anemone allergens in dogs (Cohen and Zelaya-Quesada 2002). The lessons gleaned from reviews of cases of fatal anaphylaxis may help physicians understand why people die and may help initiate management approaches that prevent anaphylaxis. With this in mind, the goal of this discussion is to highlight some of the significant findings and lessons learned from studies on fatal anaphylaxis. Exact incidence measures for anaphylaxis and fatal anaphylaxis are unknown, and many studies document under-reporting of events (Lieberman 2003). This would suggest that the data we have, underestimates the true incidence of this problem.

Not determined
Pathology and modes of death
Food anaphylaxis
Stinging insect venom anaphylaxis
Idiopathic anaphylaxis
Findings
Final comments
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.